Multipotent, self-renewing neural stem cells reside in the embryonic mouse telencephalic germinal zone. Using an in vitro neurosphere assay for neural stem cell proliferation, we demonstrate that FGF-responsive neural stem cells are present as early as E8.5 in the anterior neural plate, but EGF-responsive neural stem cells emerge later in development in a temporally and spatially specific manner. By separately blocking EGF and FGF2 signaling, we also show that EGF alone and FGF2 alone can independently elicit neural stem cell proliferation and at relatively high cell densities separate cell nonautonomous effects can substantially enhance the mitogen-induced proliferation. At lower cell densities, neural stem cell proliferation is additive in the presence of EGF and FGF2 combined, revealing two different stem cell populations. However, both FGF-responsive and EGF-responsive neural stem cells retain their self-renewal and multilineage potential, regardless of growth factor conditions. These results support a model in which separate, lineage-related EGF-and FGF-responsive neural stem cells are present in the embryonic telencephalic germinal zone.
INTRODUCTION
The vertebrate central nervous system emerges from a layer of cytologically indistinct neuroepithelial cells along the dorsal midline of the embryo, called the neural plate. The neural plate subsequently undergoes a series of morphogenetic movements to form a neural tube consisting of prominent vesicles anteriorly, which represent the anlage of the forebrain, midbrain, and hindbrain, and a slender portion posteriorly, which develops into the spinal cord. Clonal analysis has shown that single cells isolated from the neural tube along the spinal segment are competent to give rise to clones containing both dorsal (e.g., sensory ganglion neurons and presumptive pigment cells) and ventral (e.g., motor neurons and floor plate cells) derivatives, indicating that neural precursor cells at an early stage are not restricted in their potential to generate different cell types along the dorsoventral axis (Artinger et al., 1995) . Indeed, the generation of diverse cellular phenotypes has been shown to depend upon signals emanating from surrounding tissues that can regulate phenotypic and positional specification of neural precursor lineages along the rostrocaudal and dorsoventral axes (reviewed in Lumsden and Krumlauf, 1996; Tanabe and Jessell, 1996) . Although the fate of the progeny of multipotential precursors can be specified by extrinsic mechanisms at early stages of neural development, the regulation of the multipotential precursor population itself at these early stages is poorly understood. It is not known if, for example, all precursors terminally differentiate along with their progeny throughout the course of neurogenesis. The recent identification of stem cells in the embryonic and adult mammalian central nervous system (reviewed in indicates that not all lineage precursors differentiate. Therefore, the regulation of neural stem cell proliferation may be required for the initial events leading to the elaboration of neural tissue and the maintenance of discrete regions of neurogenesis in the adult brain.
Evidence from in vivo lineage analyses and in vitro cell culture experiments revealed that the rodent telencephalic germinal zone (GZ) at embryonic day (E) 14 is composed of a heterogeneous population of multipotential and committed precursor cells (Gage et al., 1995; McKay, 1997) . Neural stem cells, exhibiting the fundamental stem cell properties of multipotentiality and selfrenewal (Potten and Loeffler, 1990) , have been shown to make up a relatively small percentage of this heterogeneous E14 GZ population (Temple, 1989; Vescovi et al., 1993) . In the adult forebrain, neural stem cells are present as a relatively quiescent subpopulation in the subependyma, a remnant of the embryonic GZ (Reynolds and Morshead et al., 1994; Craig et al., 1996; Gritti et al., 1996) , and this population persists into senescence (Tropepe et al., 1997) .
Epidermal growth factor (EGF) and fibroblast growth factor-2 (FGF2) have been shown to mediate cell proliferation in the embryonic retina (Anchan et al., 1991; Lillien and Cepko, 1992) , telencephalon (Gensburger et al., 1987; Drago et al., 1991; Kilpatrick and Bartlett, 1993) , hippocampus (Ray et al., 1993) , mesencephalon (Murphy et al., 1990; Santa-Olalla and Covarrubias, 1995) , and spinal cord (Ray and Gage, 1994) . Furthermore, EGF and FGF2 are critical for the proliferation of neural stem cells isolated from the embryonic and adult forebrain GZ Vescovi et al., 1993; Gritti et al., 1996) , as well as the embryonic and adult spinal cord Kalyani et al., 1997) . FGF2 is believed to act primarily through FGF-receptor-1 (FGFR1) (Johnson and Williams, 1993) , and both receptor binding affinity and growth factor-mediated mitogenicity in many cell types, including neuroepithelial cells, are dependent on heparin (Ornitz and Leder, 1992; Roghani et al., 1994; Brickman et al., 1995) . In the rat telencephalon, FGFR1 is expressed as early as E8.5-E9.5 and this expression is relatively confined to the ventricular zone during later stages of development (Orr-Urtreger et al., 1991; Wanaka et al., 1991) , while peak expression of FGF2 occurs at midneurogenesis in predominantly postmitotic cells (Weise et al., 1993) . Targeted null mutations of FGFR1 cause defects in cell proliferation and mesoderm patterning and embryos die between E7.5 and E9.5 (Deng et al., 1994; Yamaguchi et al., 1994; Ciruna et al., 1997) . Thus, FGF-dependent cellular proliferation has a prominent and ubiquitous role during embryogenesis. The in vitro evidence for FGF-dependent proliferation of neural precursor cells and the early expression of FGFR1 in the telencephalon indicates that neural precursor cell proliferation is predominantly regulated by FGFs. Low levels of transforming growth factor-␣ (TGF␣) and the EGF-receptor (EGFR) are similarly present at relatively early stages of telencephalic development in mostly ventral regions, with an increase in intensity and dorsal distribution at later embryonic stages (Eagleson et al., 1996; Kornblum et al., 1997) . Both EGF and TGF␣ bind preferentially to the EGFR (Massague, 1983; Marquardt et al., 1984) , but TGF␣ is thought to be the predominant endogenous ligand in the rodent brain (Kornblum et al., 1997) . Although there is in vitro evidence for EGF-dependent proliferation of neural precursor cells, targeted disruption of the EGFR has no apparent neural phenotype at early stages of development, but does cause forebrain cortical dysgenesis at late embryonic and postnatal ages with evidence of an attenuated forebrain, cortical cell death, and hippocampal ectopias (Threadgill et al., 1995; Sibilia and Wagner, 1995; Sibilia et al., 1998) . Depending on the background genetic strain, the EGFR (Ϫ/Ϫ) mutation can cause implantation defects, while some mice can survive for several weeks postnatally. Both EGF and FGF2 can elicit the in vitro proliferation of neural stem cells isolated from the embryonic GZ, but evidence from the null receptor mutations suggests that there may be differential in vivo influences of these mitogens on telencephalic neural stem cell proliferation at different stages of embryonic development.
To determine if EGF and FGF2 have differential roles in neural stem cell proliferation (and indeed act on different cells) we analyzed the EGF-and FGF-responsiveness of neural stem cells from early stages of neural development, and tested whether there were quantitative and qualitative differences between the two mitogenic signals. In serum-free conditions neural stem cells proliferate in the presence of FGF2 as early as E8.5, but respond to EGF only at later stages of embryonic development. Neural stem cells independently proliferate in response to EGF and FGF2, and at low cell densities the EGF-and FGF2-induced proliferation of stem cells is additive. FGF2 signaling via FGFR1 is critical for proliferation of FGF2-responsive neural stem cells isolated from the E8.5 anterior neural plate. EGF signaling through the EGFR is critical for the proliferation of EGF-responsive neural stem cells, but not FGF2-responsive neural stem cells, isolated from the E14.5 telencephalic GZ. Furthermore, in the absence of a functional FGFR1, the expansion of the FGF2-responsive neural stem cell population, as well as the emergence of EGF-responsive neural stem cells, is severely diminished at E14.5. The distinct proliferative responses to EGF and FGF2 reveal a heterogeneity among the neural stem cell population itself. Furthermore, our results suggest that the EGF-responsive stem cells that are present in the E14.5 GZ are the lineage descendents of FGF-responsive stem cells that are present as early as E8.5. In addition, the greater than proportional increase in the number of embryonic neural stem cells proliferating in high density cultures demonstrates that the proliferation of neural stem cells can be actively regulated by additional cellular interactions that were shown to be separate of both EGF and FGF2 signaling.
MATERIALS AND METHODS
Isolation of neuroepithelial cells from embryonic day 8.5 embryos. Pregnant CD1 mice (Charles River) at the specified gestational age of 8.5 days (E8.5) were killed via cervical dislocation and the uteri were aseptically removed and transferred to petri dishes containing sterile Dulbecco's phosphate-buffered saline (PBS; GIBCO) with 30% glucose (Sigma) and 2% penicillin/streptomycin (5000 IU; GIBCO). Each decidua from the uterine sac was dissected out and transferred to a new sterile petri dish containing PBS in order to rinse away excess blood. Deciduae were then transferred to a chemically defined serum-free media composed of a 1:1 mixture of Dulbecco's modified Eagle's medium (DMEM; GIBCO) and F-12 nutrient (GIBCO) including 0.6% glucose (Sigma), 2 mM glutamine (GIBCO), 3 mM sodium bicarbonate (Sigma), and 5 mM HEPES buffer (Sigma). A defined hormone and salt mixture (Sigma) that included insulin (25 g/ml), transferrin (100 g/ml), progesterone (20 nM), putrescine (60 M), and selenium chloride (30 nM) was used instead of serum. All subsequent dissection procedures were adapted from Drago et al. (1991) . Under a dissecting microscope (Zeiss), sterile, fine forceps were used to make a single superficial incision through the narrow end of the decidual wall. The amniotic sac was gently removed and transferred to a new petri dish containing fresh media. Embryos were removed from the amniotic sac and the head primordia were dissected using fine forceps and microprobe by excising rostral to the first branchial arch. Using a sterile, fire-polished Pasteur pipette head primordia were transferred to media containing 0.1% (w/v) trypsin (Sigma) and 0.001% (v/v) deoxyribonuclease I (10 mg/ml stock DNase I; Boehringer-Mannheim) and incubated at 4°C for approximately 15 min. After enzymatic dissociation, head primordia were washed in PBS and subsequently transferred to media containing 0.7 mg/ml trypsin inhibitor (BoehringerMannheim). Anterior neural plate tissue was gently teased away from surrounding head mesenchyme and overlying epidermal ectoderm. The neuroepithelium was washed in Ca 2ϩ -Mg 2ϩ -free Hank's buffer (GIBCO) to remove loosely adherent cells. Each anterior neuroepithelium was transferred to serum-free culture media containing either 10 ng/ml FGF-2 (human recombinant; Upstate Biotech) and 2 g/ml heparin (Upstate Biotech), or 20 ng/ml EGF (mouse submaxillary; Upstate Biotech), mechanically dissociated into single cells and plated in uncoated 24-well plates (0.5 ml/well; Nunclon). Each dissection yielded an average of 5000 viable cells/well assessed using trypan blue exclusion (0.4%; GIBCO). Due to the limited amount of viable cells recovered from these small tissue samples, one E8.5 anterior neural plate dissection per well was plated. The average cell plating density was estimated at 10 cells/l (from n ϭ 6 embryos).
Isolation of ventricular zone cells from embryonic days 13.5-15.5 embryos and postnatal day 3 mice. Pregnant CD1 mice of gestational age 13.5, 14.5, or 15.5 days (E13.5, E14.5, E15.5) were killed via cervical dislocation and embryos were removed as described above. Postnatal day 3 mice were anesthetized at 4°C and decapitated. In PBS (as above) the brains of each embryo and postnatal mouse was removed and overlying meninges and blood vessels were removed. Dissected cortical or striatal GZ tissue was transferred to serum-free media and mechanically dissociated into a cell suspension with a fire-polished Pasteur pipette. Cell viability was assessed using trypan blue (as above). Cells were plated in 96-well (0.2 ml/well), 24-well (0.5 ml/well), or 6-well (2 ml/well) uncoated plates (Nunclon) depending on the experimental conditions in serum-free media containing growth factors (as above). In order to assess self-renewal, E8.5, E13.5-15.5, and P3 primary neurospheres (selecting mainly floating neurospheres after 6 -7 days in vitro) were passaged by mechanically dissociating a single neurosphere in 0.2 ml of serum-free media, in identical growth factor conditions as the primary culture, and plated in uncoated 96-well (0.2 ml/well) plates (Nunclon). Passagibility was assessed by identifying new neurospheres after a further 6 -7 days in vitro. For E14.5 and P3 dose-response experiments, the molarity values for each of the concentration points chosen are: (1) for FGF2, 0.05 ng/ml ϭ 3.5 ϫ 10 Ϫ12 M; 0.2 ng/ml ϭ 1.4 ϫ 10 Ϫ11 M; 0.6 ng/ml ϭ 3.8 ϫ 10 Ϫ11 M; 2 ng/ml ϭ 1.2 ϫ 10 Ϫ10 M; 10 ng/ml ϭ 5.7 ϫ 10 Ϫ10 M; 20 ng/ml ϭ 1.14 ϫ 10 Ϫ9 M; 40 ng/ml ϭ 2.28 ϫ 10 Ϫ9 M; 80 ng/ml ϭ 4.57 ϫ 10 Ϫ9 M; and (2) for EGF, 0.05 ng/ml ϭ 1.0 ϫ 10 Ϫ11 M; 0.2 ng/ml ϭ 4.0 ϫ 10 Ϫ11 M; 0.6 ng/ml ϭ 1.1 ϫ 10 Ϫ10 M; 2 ng/ml ϭ 3.3 ϫ 10 Ϫ10 M; 10 ng/ml ϭ 1.64 ϫ 10 Ϫ9 M; 20 ng/ml ϭ 3.28 ϫ 10 Ϫ9 M; 40 ng/ml ϭ 6.56 ϫ 10 Ϫ9 M; 80 ng/ml ϭ 1.31 ϫ 10 Ϫ8 M. For the growth factor dose-dependent clonal analyses, E14.5 GZ tissue was isolated as above and cells were plated at 4 ϫ 10 5 cells per 94-mm Greiner hybridoma tissue culture dish (Fedoroff et al., 1997) , which is subdivided into approximately 700 microwells, 0.04 cm 2 each (Greiner Labortechnik, Bellco Glass, Inc., Vineland, NJ). Using this procedure, microwells containing 0 cells, 1-3 cells, or greater than 3 cells per well were scored after approximately 24 h (randomly assorted cells), and only the wells containing 1-3 cells were followed for the 7-day culture period for the presence of neurospheres in three separate growth factor concentration conditions (0.6, 20, 80 ng/ml) for both EGF and FGF2. Single neurospheres generated in all conditions were either passaged to assay for the generation of secondary and tertiary neurospheres (as above) or plated to assess their differentiation potential (see below).
Generation of FGFR1 tetraploid and diploid chimeras. The generation of FGFR1 tetraploid and diploid chimeric mice was exactly as previously described by Ciruna et al. (1997) . Briefly, ES cell lines that were homozygous for the fgfr1 ⌬tmk allele, previously identified as a functional null mutation (Yamaguchi et al., 1994) , and marked with a ubiquitously expressed lacZ marker (Friedrich and Soriano, 1991) were used for generating chimeras (Ciruna et al., 1997) . These ES cells (as well as fgfr1 ⌬tmk /ϩ control ES cells) were aggregated with two tetraploid CD1 embryos, produced by electrofusion of embryos at the two cell stage, and aggregates were transferred to the uteri of CD1 foster mothers. Embryos were subsequently isolated at 8.5 days of gestation and anterior neural plate tissue was dissected, dissociated, and plated in serum-free media (as above) in order to assay for neurosphere formation. Diploid chimeric embryos were generated by aggregating 8 -10 cell morulae of fgfr1 ⌬tmk /fgfr1 ⌬tmk ES cells (or fgfr1 ⌬tmk /ϩ control ES cells) with CD1 8-cell embryos. Aggregates were transferred into the uteri of CD1 foster mothers, and chimeric embryos were isolated at E14.5. Striatal GZ tissue was dissected from one hemisphere (the other was used for X-gal staining-see below), dissociated and plated in serum-free media (as above), and the number of neurospheres generated in the presence of either EGF or FGF2 was assayed after 7 days. Tetraploid and diploid chimeric animals will be refered to as ROSA26-FGFR1 (Ϫ/Ϫ) or ROSA26-FGFR1 (ϩ/Ϫ) , mutant, and control, respectively, throughout.
Whole mount ␤-Gal staining for E14.5 chimeric embryonic brains and neurospheres. E14.5 embryonic brain hemispheres (or neurospheres) generated from the E14.5 diploid chimeras were rinsed in 100 mM sodium phosphate buffer (pH 7.4) and then fixed in 0.2% gluteraldehyde, 2 mM MgCl 2 , 5 mM EDTA, and 100 mM sodium phosphate (pH 7.3) at room temperature for 5 min (neurospheres) or 15 min (brains). Single brain hemispheres (or neuro-spheres) were then washed (3ϫ) in wash buffer containing 0.02% NP-40, 0.01% deoxycholate, 2 mM MgCl 2 , and 100 mM sodium phosphate (pH 7.3) for 5-15 min each. Brain hemispheres (or neurospheres) were stained in 1 mg/ml X-gal, 5 mM K 3 Fe(CN) 6 , 5 mM K 4 Fe(CN) 6 , 0.02% NP-40, 0.01% deoxycholate, 2 mM MgCl 2 , and 100 mM sodium phosphate buffer (pH 7.3) at 37°C overnight. Single brain hemispheres (or neurospheres) were then rinsed with wash buffer and stored at 4°C. For forebrain sections, brain hemispheres were postfixed overnight in 4% paraformaldehyde at 4°C, subsequently cryoprotected with 20% sucrose, cryosectioned at 14 m, and then counterstained with 0.5% safranin (stains the entire cell light red). In order to estimate the percent chimerism in the striatal germinal zone region, four to six sections (obtained from every 10th serial section through the forebrain) were used to determine the proportion of blue (X-gal-positive) cells. Cell counts (a total of approximately 500 cells counted in any one section) were obtained using a phase-contrast Nikon microscope (20ϫ objective).
Genotyping mouse embryos from EGFR heterozygote matings. Targeted disruption of the mouse EGFR was carried out as previously described (Sibilia and Wagner, 1995) . A total of 12 pregnant female mice, from EGFR heterozygote matings (129/B6xB6) were analyzed in order to obtain an adequate number of mutant embryos. DNA was prepared from yolk sacs or tails and genotyped by PCR and primers used for amplification of wild-type and mutant alleles was as previously described (Sibilia and Wagner, 1995) .
Dose-response analysis for EGFR-inhibitor and Anti-FGF2 antibody effects on neurosphere formation. The generation of primary neurospheres isolated from the E14.5 GZ (1 ϫ 10 5 cells in 2 ml) in the presence of EGF (20 ng/ml) and various concentrations of the EGFR inhibitor (referred to as PD) (Park Davis, PD 153035; Fry et al., 1994) was determined. At plating densities of 50 cells/l and n ϭ 6 embryos for each group, the number of neurospheres (mean percentage of control Ϯ SEM) generated were as follows: Dimethyl sulphoxide (DMSO) control ϭ 100 Ϯ 9.0; 0.0036 M PD ϭ 51.5 Ϯ 8.5; 0.032 M PD ϭ 3.24 Ϯ 0.9; 0.16 M PD ϭ 2.37 Ϯ 0.8; 0.8 M PD ϭ 1.45 Ϯ 0.4. Since there was some evidence for reduced viability at the 0.8 M concentration, we used 0.16 M for subsequent analyses, which resulted in similar viability to the DMSO control. The same analysis was performed for the anti-FGF2 antibody (IgG, Upstate Biotech) in the presence of FGF2 (10 ng/ml) and heparin (2 g/ml) at plating densities of 50 cells/l and n ϭ 6 embryos for each group. A nonspecific control antibody (conAb) of similar species (mouse) and isotype (anti-MAP2 monoclonal IgG) was also used to compare to the PBS control. The percentages of neurospheres (mean percent of PBS control Ϯ SEM) generated were as follows: PBS control ϭ 100 Ϯ 5.0; 0.125 g/ml conAb ϭ 100.5 Ϯ 5.2; 1.25 g/ml conAb ϭ 96.6 Ϯ 5.5; 0.125 g/ml anti-FGF2 ϭ 12.4 Ϯ 2.14; 1.25 g/ml antiFGF2 ϭ 1.14 Ϯ 0.6; 12.5 g/ml anti-FGF2 ϭ 0.21 Ϯ 0.1. There were no significant differences between the PBS control and the conAb conditions. There was some evidence for compromised viability at the 12.5 g/ml concentration of the anti-FGF2. Therefore, we used 1.25 g/ml anti-FGF2 for subsequent analyses, which resulted in similar viability of cells when compared to the PBS control and the 1.25 g/ml conAb.
Cryosectioning neurospheres. Using a Pasteur pipette, neurospheres cultured for 6 or 7 days in vitro were transferred and washed (2ϫ) in 10 mM phosphate-buffered saline (PBS, pH 7.2) for a few seconds for each wash. Neurospheres were then transferred to 4% paraformaldehyde containing 0.4% picric acid in 0.16 M phosphate buffer (pH 6.9) (Zamboni and de Martino, 1967) and fixed for 1 h at room temperature. Neurospheres were washed (3ϫ) in 10 mM PBS for 5 min each prior to being resuspended in 10% sucrose (in 10 mM PBS) overnight at 4°C. The following day, neurospheres were placed in tissue freezing media (Tissue Tek) in order to quick freeze to Ϫ50°C. Using a cryostat, serial 14-m sections were taken and collected on gelatin-coated slides. Slides were stored at Ϫ70°C.
Immunocytochemistry on sectioned whole neurospheres. Gelatin-coated slides containing neurosphere sections were allowed to rehydrate with PBS for 10 min. For nestin immunocytochemistry, a rabbit polyclonal antiserum (a gift from Dr. R. McKay) (Tohyama et al., 1992) was diluted to 1:1000 (in PBS ϩ Triton-X) and sections were incubated overnight at 4°C. Sections were then washed (3ϫ) in 10 mM PBS (5 min each) and subsequently incubated with secondary anti-rabbit FITC-conjugated antibody (1:200; Sigma) for 1 h at room temperature. Sections were washed (3ϫ) (5 min each) and then cover-slipped with Fluor-mount mounting medium. Fluorescence was detected on a Nikon microscope. For EGFR (Sugiyama et al., 1989) and FGFR1 (Werner et al., 1993) immunocytochemistry, neurosphere sections were rehydrated with PBS for 10 min and incubated overnight at 4°C in sheep anti-mouse EGF-receptor (1:100; Biodesign International) in PBS containing 0.3% Triton-X and 10% donkey serum. Sections were rinsed with PBS for 10 min and then incubated in Cy3 donkey anti-sheep secondary antibody (1:300; Jackson ImmunoResearch) in PBS containing 0.3% Triton-X and 10% donkey serum. After rinsing in PBS for 10 min, sections were incubated in rabbit anti-mouse FGF-receptor-1 (1:250; a gift from Dr. L. Williams) in PBS containing 0.3% Triton-X and 10% donkey serum. Sections were again rinsed with PBS for 10 min and subsequently incubated in biotinylated donkey anti-rabbit (1:200; Jackson ImmunoResearch) for 1 h at 37°C, followed by rinsing in PBS for 10 min, and finally incubated in streptavidin Cy2 (1:1000; Jackson ImmunoResearch) in PBS only for 1 h at 37°C. Sections were rinsed (2ϫ) for 10 min each and cover-slipped in Fluor-mount. Fluorescence was detected on a Nikon Microphot microscope.
Immunocytochemistry on differentiated neurospheres. Six days after primary culture, single neurospheres were transferred using a Pasteur pipette onto glass coverslips coated with MATRI-GEL basement membrane matrix (15.1 mg/ml stock solution diluted 1:50 in serum-free media; Becton-Dickinson) in individual wells of a 24-well culture plate (Nunclon) (0.5 ml/well) in serumfree media containing various growth factor concentrations, or in media containing 10% FBS and no extra growth factor. Media was not changed for the rest of the culture period. Coverslips were processed 6 -7 days later using immunocytochemistry. Coverslips were fixed in 4% paraformaldehyde (in PBS, pH 7.2) for 30 min at room temperature followed by 3 (5 min each) washes in PBS (pH 7.2). Cells were then permeabilized for 5 min in PBS containing 0.3% Triton-X, rinsed for 5 min (2ϫ) in PBS and blocked for 1 h in PBS containing 10% normal goat serum (NGS). After blocking, coverslips were incubated in anti-MAP-2 mouse monoclonal (IgG) (1:1000; Boehringer-Mannheim) and anti-GFAP rabbit polyclonal (IgG) (1:400; Chemicon) antibodies diluted in PBS containing 10% NGS for 2 h at 37°C. Coverslips were then rinsed in PBS three times (5 min each) and subsequently incubated in FITC goat anti-rabbit (1:200; Jackson ImmunoResearch) and TRITC goat anti-mouse (1:200; Jackson ImmunoResearch) secondary antibodies at 37°C for 30 min. Coverslips were rinsed three times (5 min each) in PBS. Separate coverslips (from similar culture conditions) were used for oligodendrocyte staining. Coverslips were incubated in anti-O4 mouse monoclonal (IgM) antibody (1:40; BoehringerMannheim) in PBS containing 10% NGS at 4°C overnight. The next day, coverslips were rinsed three times (5 min each) and subsequently incubated in DTAF goat anti-mouse-IgM (1:200; Jackson ImmunoResearch) secondary antibody in PBS containing 10% NGS at 37°C for 30 min. After rinsing three times (5 min each), all coverslips were incubated in Hoechst 33258 nuclear stain (0.015 mg/ml stock solution diluted to 0.001 mg/ml; BoehringerMannheim) for 20 min at room temperature.
For secondary neurospheres generated from primary clonal microwell cultures in various concentrations of EGF or FGF2 (see above), triple-labeling was performed. The procedure was identical to the above described double-labeling procedure except that the secondary antibody used to detect GFAP-positive cells was an AMCA goat anti-rabbit antibody (1:200 dilution; Jackson ImmunoResearch) and counterstaining with Hoechst was not performed. All coverslips were rinsed for 5 min in PBS (3ϫ) and mounted in Fluormount. Fluorescence was visualized using a Nikon Microphot microscope. Secondary antibody-only control coverslips were processed simultaneously using the identical protocol except dilution solutions were devoid of primary antibodies. All secondary controls were negative for staining.
Limiting dilution analysis. Limiting dilution analysis was performed according to Bellows and Aubin (1989) . Cells isolated from the E14.5 striatal germinal zone were plated in 96-well microwell plates containing either EGF (20 ng/ml), FGF2 (10 ng/ml) ϩ heparin, or EGF ϩ FGF2 ϩ heparin. Cell numbers were adjusted to give a starting concentration of 4000 cells/ml from which serial dilutions were made. Final cell dilutions ranged from 500 cells per well to 1 cell per well in 0.2-ml aliquots. Cultures were left undisturbed for approximately 7 days after which time the fraction of wells not containing neurospheres for each cell plating density was calculated and those points were plotted against the number of cells plated per well. The number of cells required to form one neurosphere, which reflected the proportion of neural stem cells in the entire population, was then determined from the point at which the line crossed the 0.37 level. That is, F 0 ϭ e Ϫx , where F 0 is the fraction of wells without neurospheres and x is the mean number of cells per well. Based upon a Poisson distribution of cells, F 0 ϭ 0.37 corresponds to the dilution at which there is one neural stem cell per well.
RESULTS

Neural Stem Cells Differentially Proliferate in Response to EGF and FGF Depending on Embryonic Age and Telencephalic Region
Given that neural stem cells are the lineage precursors to neuronal and glial progenitors, they are likely to be present in the GZ prior to E14 since postmitotic neurons are present in the mouse forebrain as early as E11 (Smart and Smart, 1982) . Neural stem cells isolated from the E14 striatal GZ have been shown to proliferate in response to EGF and FGF2 in serum-free culture conditions to give rise to clonal aggregates of undifferentiated neural precursors, called neurospheres Vescovi et al., 1993) . E14 neural stem cells have the classical properties of self-renewal and multipotentiality . To determine if neural stem cells are present at very early stages of development, prior to neural tube formation, anterior neural plate tissue was isolated from E8.5 embryos and plated in the presence of EGF or FGF2. Neurospheres were generated from E8.5 anterior neural plate tissue in the presence of FGF2 alone, but not in EGF alone (Fig. 1A) . Increasing the concentration of EGF from 20 to 80 ng/ml did not cause neurospheres to form; whereas, increasing the concentration of FGF2 to 80 ng/ml did not significantly increase the number of neurospheres generated compared to 10 ng/ml of FGF2 (data not shown). Single FGF2-generated primary neurospheres from E8.5 anterior neural plate were capable of generating secondary neurospheres when passaged in either EGF (3.86 Ϯ 1.0 secondary neurospheres generated from a single primary neurosphere, n ϭ 7) or FGF2 (5.42 Ϯ 1.3 secondary neurospheres generated from a single primary neurosphere, n ϭ 7). This suggests that the cells isolated at E8.5 are not only capable of self-renewal in FGF2, but also that single FGF-responsive cells can give rise to stem cells capable of generating neurospheres in EGF. Based on our estimate of the numbers of viable cells isolated and plated from a single embryonic anterior neural plate dissection (ϳ5000; see Materials and Methods), the estimated frequency of neural stem cells that proliferate in the presence of FGF2 at this early developmental age was approximately 0.3% in the anterior neural plate. Thus, self-renewing neural stem cells are present in the developing nervous system as early as E8.5 and are competent to proliferate in response to FGF2, but not EGF. Furthermore, FGF-responsive stem cells at E8.5 appear to be the lineage precursors to EGF-responsive stem cells.
Since neural stem cells are not responsive to EGF at E8.5, but do proliferate in response to EGF at E14.5, we asked if the growth factor responsiveness of neural stem cells was dependent on the developmental stage and spatial localization within the telencephalic GZ (i.e., the cortical and striatal germinal zones, the major E14.5 telencephalic derivatives of the anterior neural plate germinal zone). Neural tissue was isolated from the striatal GZ and cortical GZ at E13.5, E14.5, and E15.5. At E13.5 the numbers of neurospheres generated per numbers of cells plated from both the cortical GZ and striatal GZ in the presence of EGF was significantly less than the numbers of neurospheres generated in the presence of FGF2 (Fig. 1B) . By E14.5, more neurospheres were generated per numbers of cells plated in FGF2 compared to EGF from the striatal GZ; however, significantly fewer EGF-generated neurospheres than FGF2-generated neurospheres were isolated from E14.5 cortical GZ. At E15.5, the numbers of neurospheres generated from both the cortical GZ and striatal GZ were not significantly different in the presence of either EGF or FGF2 (Fig. 1B) . Therefore, FGF2-responsive neural stem cells are present before EGF-responsive neural stem cells in both the striatal and cortical GZs. By E15.5, however, similar numbers of EGF-and FGF2-responsive neural stem cells are found within the striatal GZ or within the cortical GZ.
To determine if the single cells giving rise to the neurospheres were in fact multipotential, individual neurospheres were plated down on coverslips and cultured in the presence of 10% fetal bovine serum (FBS), or in similar concentrations of EGF or FGF2 as the primary or secondary neurosphere cultures without FBS (see below) to allow for differentiation. After 6 days in vitro, the cultures were processed for immunocytochemistry to detect neuronal and glial cell types. Under these conditions, single neurospheres generated from each of the E8.5 anterior neural plate and the E14.5 striatal GZ and cortical GZ each contained neurons (MAP2 ϩ ), astrocytes (GFAP ϩ ), and oligodendrocytes (O4 ϩ ) (Fig. 1C ). These findings indicate that multipotential neural stem cells are present at the earliest stages of development, and that FGF-dependent proliferation of neural stem cells occurs earlier in embryogenesis than the EGF-dependent proliferation of these cells.
Overlapping Expression of EGF-Receptor, FGFReceptors, and Nestin in the Cells of Neural Stem Cell-Derived Neurospheres
Since both the EGF-receptor (EGFR) and the FGFreceptor-1 (FGFR1) are expressed in the E14 forebrain germinal zone it was of interest to determine if each of the EGF-responsive and FGF-responsive neurospheres expressed a single receptor or both receptors. There is indirect evidence that the in vivo distributions of these two receptors in the E14.5 germinal zone are not completely overlapping. Eagleson et al. (1996) reported that the greatest inten- Neural stem cells isolated from the E8.5 anterior neural plate proliferate to form neurospheres after 7 days in vitro in the presence of FGF2 (10 ng/ml; n ϭ 22 embryos) and heparin, but not in the presence of EGF (20 ng/ml; n ϭ 20 embryos). Cells plated at an average density of 10 cells/l (0.5 ml/well) from at least three separate experiments. (B) Neurospheres generated in EGF (20 ng/ml; n ϭ 6 embryos) or FGF2 (10 ng/ml; n ϭ 6 embryos) and heparin from striatal and cortical GZ cells isolated at E13.5, E14.5, and E15.5 and plated in duplicate at a density of 10 cells/l (0.2 ml/well). Note that the Y axes change with age. *Indicates P Ͻ 0.05 compared to immediately adjacent bar. (C) Representative triple-immunocytochemical labeling for neurons (anti-MAP2 ϩ ), astrocytes (anti-GFAP ϩ ), and oligodendrocytes (anti-O4 ϩ ) derived from a single E14.5 neurosphere cultured for 6 -7 days in serum-free media and then allowed to differentiate for a further 6 -7 days in media containing 10% FBS. All three cell types are present in neurospheres generated from either the E8.5 anterior neural plate or the E13.5-E15.5 telencephalic GZ. Scale bar, 25 m. sity of EGFR immunostaining was observed in the subventricular zone, while others report intense FGFR1 mRNA levels in the ventricular zone (Wanaka et al., 1991) , suggesting that subpopulations of neural precursors may express only one type of receptor in slightly different regions of the forebrain germinal zone. In order to determine if neural stem cells isolated in EGF or FGF2 expressed either EGFR, FGFR1, or both, neurospheres were generated in the presence of either EGF or FGF2. After 6 days in culture, 14-m cryosections from single neurospheres were obtained and processed for EGFR, FGFR1, and nestin immunocytochemistry.
Single neurospheres from a primary culture can be dissociated into single cells, whereupon a small percentage of these cells generate new neurospheres . Thus, only a small percentage of all of the cells within a neurosphere are neural stem cells, thought to be derived from the symmetrical division of the initial stem cell, and the remaining cells are neural progenitor cells.
Since the intermediate filament protein nestin is expressed in all neural precursor cells (Lendahl et al., 1990) , we reasoned that a qualitative analysis of the expression pattern of the two growth factor receptors and nestin within a single neurosphere generated in either EGF or FGF2 would be useful in identifying any precursor cells, some of which are stem cells, within a neurosphere that express only one or both growth factor receptors. The analysis revealed that virtually all of the cells within a single neurosphere express nestin regardless of the growth factor conditions used to generate the neurospheres (Fig. 2D) . These results are consistent with previous reports that virtually all cells within neurospheres generated from the adult subependyma express nestin (Gritti et al., 1996) . The expressions of the EGFR ( Fig. 2A ) and of FGFRs (Fig. 2B ) also were ubiquitous throughout the cells in the neurospheres, similar to nestin. Double-labeling revealed that virtually all cells derived from a neural stem cell clone (isolated in either EGF or FGF2) express both EGFR and FGFR (Fig. 2C) . However,
FIG. 2.
Expression of nestin, EGFR, and FGFR1 in neural stem cell-derived neurospheres. Neurospheres generated from E14.5 GZ tissue cultured for 6 days in vitro in the presence of either EGF (20 ng/ml) or FGF2 (10 ng/ml) and heparin (2 g/ml) were fixed and cryosectioned at 14 m and immunocytochemically labeled for EGFR (red) (A), FGFR1 (green) (B), EGFRϩFGFR1 (yellow) (C), and nestin ( there were varying levels of expression of these receptors in the individual cells, and there were a few single cells within each neurosphere which express mostly EGFR or mostly FGFR (Fig. 2E) . The presence of these few cells dominated by the expression of one receptor suggests the possibility that there may be a maintenance of a small number of differentially sensitive neural stem cells that remain undifferentiated and capable of self-renewal. Given that cells in the neurospheres generated in either EGF or FGF2 express both growth factor receptors and that neurospheres can be passaged in either EGF or FGF2 regardless of initial growth factor conditions (data not shown), then we conclude that the stem cell initially responsive to either EGF or FGF2 can subsequently generate more stem cells that are responsive to both mitogens.
The Proliferative Response of Neural Stem Cells to Different Concentrations of EGF and FGF2 Is Dependent upon Cell Density
Although a single neural stem cell can proliferate to form a neurosphere in vitro, the factors affecting the proliferative behavior of neural stem cells among a population of precursors, a situation more akin to the in vivo GZ environment, is poorly understood. We examined whether the proliferative response of neural stem cells in the presence of varying concentrations (see Materials and Methods for conversions from molarity to ng/ml) of EGF and FGF2 was cell densitydependent by assaying the number of neurospheres generated from a primary E14.5 GZ dissection. A dose-response analysis revealed that at high cell densities (50 cells/l) and low mitogen concentrations (0.05-2 ng/ml), EGF was an order of magnitude more effective than FGF2 in generating neurospheres, but at higher concentrations (10 -80 ng/ml) both EGF and FGF2 elicited the proliferation of the same maximal number of neural stem cells to form neurospheres (Fig. 3A) . However, at relatively lower densities (10 cells/l) and low mitogen concentrations, FGF2 was more effective than EGF in generating neurospheres and FGF2 generated a higher maximal number of neurospheres at higher concentrations (Fig. 3B) . Furthermore, the maximal numbers of neurospheres were more than proportionally higher at the high compared to the low densities. The fivefold increase in cell density (from 10 to 50 cells/l) produced a greater than 10-fold increase in the number of neurospheres generated, thus demonstrating cell nonautonomous effects that facilitate neural stem cell proliferation.
The self-renewing capacity of the stem cells that formed the neurospheres was assayed for at least one passage by dissociating single spheres isolated from low (0.6 ng/ml) and high (20 ng/ml) growth factor concentration conditions from both low and high density primary cultures, and counting the number of secondary neurospheres generated. When single neurospheres generated from high density cultures (50 cells/l) in 0.6 ng/ml of EGF or FGF2 were dissociated in the same growth factor conditions, new neurospheres were generated after ϳ7 days in either EGF (9.3 Ϯ 1.7, n ϭ 8) or FGF2 (6.4 Ϯ 1.8, n ϭ 8), respectively. Single neurospheres generated in high density cultures in 20 ng/ml of EGF or FGF2 were dissociated, secondary neurospheres were generated in either EGF (19.6 Ϯ 3.9, n ϭ 8) or FGF2 (20.4 Ϯ 2.4, n ϭ 8) ,   FIG. 3 . Dose-dependent proliferation of neural stem cells isolated from the E14.5 and P3 forebrain GZ in EGF and FGF2 is sensitive to cell density. Neurospheres generated from neural stem cells isolated from the E14.5 GZ (n ϭ 6 embryos/concentration) and plated at either a density of 50 cells/l (A) or 10 cells/l (B), and from neural stem cells from the P3 GZ (n ϭ 6 embryos/ concentration) and plated at 10 cells/l (C) in varying concentrations (molarity) of EGF or of FGF2 with heparin.
respectively. Similarly, in experiments where single neurospheres generated from low density cultures (10 cells/l) in 0.6 ng/ml of EGF or FGF2 were dissociated in the same growth factor conditions, new neurospheres were generated in either EGF (13.2 Ϯ 2.0, n ϭ 12) or FGF2 (5.0 Ϯ 1.3, n ϭ 12), respectively. Single neurospheres generated in low density cultures in 20 ng/ml of EGF or FGF2 were dissociated, secondary neurospheres were generated in either EGF (16.5 ϩ 2.6, n ϭ 12) or FGF2 (12.8 ϩ 1.8, n ϭ 12), respectively. Thus, the single neurosphere passaging data demonstrate that individual neural stem cells, regardless of cell density and growth factor concentration, can self-renew and expand the stem cell population through symmetrical divisions.
The proportionally greater maximal numbers of neurospheres generated at high density (EGF or FGF2) reflects a cell nonautonomous potentiation of neural stem cell proliferation at higher densities. Furthermore, the greater maximal numbers of neurospheres generated in FGF2 at low densities, compared to the same maximal number of EGF-and FGF2-generated neurospheres at high densities ( Fig. 3B versus 3A) , indicates that these cell nonautonomous effects may have a greater influence on EGFresponsive stem cell proliferation. The finding that low density cultures appeared to produce a leftward shift from high density cultures in the dose-responsiveness of FGF2 on E14.5 neurosphere formation, compared to the relatively stable EGF dose-responsiveness regardless of cell density, may suggest that FGF2 has a greater affinity for its receptor at lower densities. This may be due to the decreased availability of the FGF2 ligand (or heparin) at higher cell densities or perhaps due to the down regulation of FGF receptors on stem cells at high cell densities.
The relative number of stem cells present in higher cell density cultures is greater than the number of stem cells in low density cultures. Since a relatively greater number of neural stem cells also can be isolated from older than younger embryonic GZs (see above), it is possible that the interactions between the older stem and progenitor cells may facilitate the observed cell nonautonomous effects in vivo, and that neural stem cells isolated from older GZ tissue and cultured at low densities will behave as neural stem cells isolated from younger GZ tissue and cultured at higher cell densities. In order to determine if the cell density-dependent facilitation observed reflects an agedependent maturation phenomenon or is a true reflection of stem and progenitor cell interactions dependent only on cell density and not on age, we examined the dosedependent proliferation of neural stem cells isolated from the postnatal day (P) 3 mouse forebrain at low densities. The results demonstrate that the dose-dependent proliferation of neural stem cells isolated from the P3 GZ and cultured at low densities is similar to the dose-dependent proliferation of neural stem cells isolated from the E14.5 GZ at low densities (Fig. 3C) . These results show that the dose-dependent proliferation of neural stem cells depends on cell density and not on the developmental stage at which stem cells are analyzed.
To further determine that the concentration of exogenous EGF or FGF2 does not select for progenitor cells that are differentially sensitive to varying growth factor concentrations in these serum-free culture conditions, we used microwell culture dishes (see Materials and Methods) and seeded E14.5 striatal GZ cells at clonal densities in various concentrations (0.6, 20, or 80 ng/ml) of either EGF or FGF2 separately. Microwells containing 1-3 cells (6 h after plating) were followed for 7 days in order to assess neurosphere formation. Single primary neurospheres generated in these conditions were dissociated and replated in the identical growth factor concentration conditions to determine the self-renewal capacity of the neurosphere forming cells. Individual primary neurospheres derived from single cells in FGF2 (0.6, 20, or 80 ng/ml) demonstrated the ability to generate new (secondary) neurospheres upon dissociation in either 0.6 ng/ml (6.6 Ϯ 2.3 secondary neurospheres from each primary neurosphere, n ϭ 12), 20 ng/ml (29.9 Ϯ 7.9, n ϭ 12), or 80 ng/ml (73.9 Ϯ 20.4, n ϭ 12) of FGF2. Similarly, individual neurospheres derived from single cells in EGF (0.6, 20, or 80 ng/ml) demonstrated the ability to generate secondary neurospheres upon dissociation in either 0.6 ng/ml (39.5 Ϯ 9.9, n ϭ 8), 20 ng/ml (81.4 Ϯ 24.2, n ϭ 11), or 80 ng/ml (83.4 Ϯ 18.2, n ϭ 10) of EGF. Moreover, individual secondary neurospheres from each of these growth factor conditions demonstrated the ability to generate tertiary neurospheres (in the identical growth factor conditions) after a second passage. Individual secondary neurospheres derived from single primary neurospheres in FGF2 (0.6, 20, or 80 ng/ml) demonstrated the ability to generate tertiary neurospheres upon dissociation in either 0.6 ng/ml (3.0 Ϯ 0.7, n ϭ 5), 20 ng/ml (21.5 Ϯ 4.9, n ϭ 8), or 80 ng/ml (36.3 Ϯ 16.8, n ϭ 6) of FGF2. Similarly, individual secondary neurospheres derived from single primary neurospheres in EGF (0.6, 20, or 80 ng/ml) demonstrated the ability to generate tertiary neurospheres upon dissociation in either 0.6 ng/ml (12.3 Ϯ 3.2, n ϭ 6), 20 ng/ml (35.8 Ϯ 11.2, n ϭ 8), or 80 ng/ml (47.4 Ϯ 15.3, n ϭ 8) of EGF. All primary, secondary, and tertiary neurospheres generated in 0.6 ng/ml FGF2 (and many, but not all in 0.6 ng/ml EGF) were smaller than the neurospheres generated in higher growth factor concentrations. Because the majority of the cells within neurospheres express EGF and FGF receptors (see above), this likely reflects the inability of all of the cells within the neurospheres to fully proliferate in these low concentration conditions and thus reducing the overall size (and number of stem cell progeny) of the neurospheres. These results show that single neural stem cells that clonally generate neurospheres in varying concentrations of growth factors can self-renew.
In order to test that the self-renewing stem cells from different growth factor concentrations remain multipotential, single secondary neurospheres generated from the primary neurosphere cultures (microwell assay) in either EGF or FGF2 (from 0.6, 20, and 80 ng/ml conditions) were allowed to differentiate in the identical growth factor conditions on an adhesive substrate, which facilitates differentiation of cells within the neurospheres (see below). Triple immunolabeling for the presence of neurons (MAP2 ϩ cells), astrocytes (GFAP ϩ cells), and oligodendrocytes (O4 ϩ cells) demonstrated that in virtually all growth factor concentration conditions, secondary neurospheres contained neurons, astrocytes, and oligodendrocytes (Fig. 1C) . These results are consistent with the immunostaining data (Table 1) from low cell density cultures (see below). However, no O4 ϩ oligodendrocytes were observed from secondary neurospheres generated in 0.6 ng/ml of FGF2 and plated in 0.6 ng/ml of FGF2 (but can form if serum is present; see below). This result is also consistent with the immunolabeling data (Table 1) obtained from low density cultures in the same growth factor concentration conditions without serum. Therefore, neural stem cells proliferate in EGF and FGF2 to form clonally derived neurospheres in a dose-dependent manner and retain their self-renewing and multilineage potential.
EGF and FGF2 Elicit Neural Stem Cell Proliferation through Independent Signaling Mechanisms
One possible explanation for the observed cell nonautonomous proliferative effects at high densities may be that in response to the application of exogenous growth factor, neural stem cells regulate their proliferation through the release of endogenous factors in an autocrine/paracrine manner. For example, Kilpatrick and Bartlett (1995) demonstrated that the proliferation of EGF-responsive E17 cortical precursors could be attenuated with the addition of inositol hexakisphosphate, which blocks the binding of FGF2 to the extracellular domain of its receptor, suggesting that the EGF-dependent proliferation of E17 cortical precursors was also dependent upon the endogenous release of FGF2. We asked whether neural stem cell proliferation in the presence of exogenous EGF or FGF2 (the only known critical mitogens for stem cell proliferation) was also dependent upon the endogenous release of either FGF2 or EGF, respectively.
We utilized E14.5 EGF-receptor null (EGFR (Ϫ/Ϫ) ) embryos ( Fig. 4A) (Sibilia and Wagner, 1995) and tested whether neural stem cell proliferation in FGF2 was attenuated in an EGFR (Ϫ/Ϫ) background. The number of neurospheres generated from high density (50 cells/l) cultures of E14.5 VZ from EGFR (Ϫ/Ϫ) mice in the presence of EGF was decreased by greater than 90% compared to littermate EGFR (ϩ/ϩ) controls (P Ͻ 0.05); however, the generation of large numbers of neurospheres in the presence of FGF2 was not affected in these mutants (Fig. 4B ). This result indicates that the endogenous release of EGF was not necessary for FGF-dependent neural stem cell proliferation, but that signaling through the EGFR was critical for EGF-dependent proliferation.
Neural tissue malformation and early embryonic lethality precluded an analysis of EGF-and FGF-dependent neural stem cell proliferation in FGFR1 (Ϫ/Ϫ) E14.5 mouse GZ (Deng et al., 1994; Yamaguchi et al., 1994) . However, utilizing tetraploid chimeric mutant mice (ROSA26-FGFR1 (Ϫ/Ϫ) ) with a transient rescue of the early embryonic phenotype (due to the tetraploid dominance of extraembryonic tissue) (Ciruna et al., 1997) , we observed a large attenuation (approximately 80% decrease) in the number of neural stem cells proliferating in the presence of FGF2 from at E8.5 (Fig. 4C) . The lack of a complete attenuation in neurosphere formation in the ROSA26-FGFR1 (Ϫ/Ϫ) mutant may indicate that FGF2 may also produce a minor activation of other members of FGF receptor family at this early stage of development. Nonetheless, signaling through the FGFR1 is critical for most FGF2-dependent neural stem cell proliferation.
In order to more clearly define the role for endogenous growth factor release, we further tested if the secondary release of FGF2 upon EGF stimulation, and vice versa, affected neural stem cell proliferation by blocking FGF2 signaling with an anti-FGF2 neutralizing antibody (Matsuzaki et al., 1989) , which prevents the ligand from binding to its receptor, and blocking EGF signaling with a synthetic EGFR inhibitor (PD 153035), which selectively disables EGF signaling by binding to the tyrosine kinase domain of the EGFR (Fry et al., 1994) . The number of neurospheres generated from high density (50 cells/l) cultures of E14.5 GZ in the presence of FGF2 and anti-FGF2 antibody (1.25 Percentage of oligodendrocytes (n) 20 ng/ml EGF 6.1 ϩ 0.7 (4) 56.3 ϩ 6 (6) 2.6 ϩ 0.3 (3) 0.6 ng/ml EGF 2.6 ϩ 0.3 (6) 54.1 ϩ 3.7 (6) 0.7 ϩ 0.2 (6) 10 ng/ml FGF2 15.4 ϩ 2.0 (5) 56.4 ϩ 5.3 (6) 1.9 ϩ 0.3 (5) 0.6 ng/ml FGF2 11.7 ϩ 2.5 (6) 57.8 ϩ 7.9 (4) 0.0 ϩ 0.0 (6) Note. Neural stem cells isolated from the E14.5 VZ in different concentrations of EGF or FGF2 were cultured for 6 days in vitro and then transferred to coated coverslips and allowed to differentiate for a further 7 days in the same growth factor conditions. Coverslips were processed for MAP2 (neurons), GFAP (astrocytes), and O4 (oligodendrocytes) using immunocytochemistry. g/ml) was decreased by almost 100% (P Ͻ 0.05), compared to the number of neurospheres generated in the presence of FGF2 and a nonspecific control antibody (matched for species and isotype similarity) (Fig. 5A) . However, there was no difference in the number of neurospheres generated in the presence of EGF and the anti-FGF2 antibody, compared to controls in EGF (Fig. 5A) . The EGFR inhibitor (0.16 M) did not block neural stem cell proliferation in the presence of FGF2, but was effective in eliminating neural stem cell proliferation in the presence of EGF (Fig. 5B) . These results show that EGF and FGF2 stimulate neural stem cell proliferation in high density cultures through completely independent signaling mechanisms.
To determine if the cell nonautonomous effects that increased neural stem cell proliferation at high cell densities obscured any putative endogenous EGF or FGF2 signaling in response to exogenous growth factor, we tested the effects of blocking EGF signaling (EGFR inhibitor) or FGF2 signaling (anti-FGF2 antibody) in lower cell density cultures (10 cells/l), where the influence of these cellular interactions on neurosphere formation is less. A similar result was observed when the same experiment was performed at cell plating densities of 1 cell/l, a condition that diminishes the cell nonautonomous effects even further (data not shown). Therefore, the results demonstrate that even at low cell density, secondary release of FGF2 in response to EGF (Fig. 5C ) or secondary release of EGF in response to FGF2 (Fig. 5D) does not contribute to the numbers of neural stem cells that proliferate to form neurospheres in vitro. Thus, the facilitative cell nonautonomous effects at either high (50 cells/l) or lower (10 cells/l) cell densities are likely due to additional unknown endogenous factors and not due to endogenous EGF or FGF2 signaling. High cell density E14.5 GZ cultures sometimes results in a very small number of neural stem cells clonally proliferating to form neurospheres in the presence of serumfree media without exogenous growth factors (3.8 Ϯ 1.2, n ϭ 6), which is never observed at lower cell densities. Thus, although the unknown mitogenic factor(s) that mediate this proliferation are not sufficient alone to account for the robust facilitative cell nonautonomous effects observed in the presence of exogenous EGF or FGF2, this does not preclude the possibility that these unknown factors may interact with the exogenous growth factors to substantially enhance neural stem cell proliferation.
FIG. 4.
Neural stem cells proliferate independently of EGFR signaling in response to FGF2, but FGFR1 signaling is critical for FGF2-dependent neural stem cell proliferation. (A) The panel shows PCR analysis of genomic DNA isolated from E14.5 EGFR (ϩ/ϩ), (ϩ/Ϫ), and (Ϫ/Ϫ) mice. The expected mutant (1.8 kb) and wild-type (1.3 kb) bands are indicated. (B) Neurospheres generated (mean as a percentage control Ϯ SEM) from neural stem cells isolated from the E14.5 GZ of EGFR (Ϫ/Ϫ) (n ϭ 5) and EGFR (ϩ/ϩ) (n ϭ 6) embryos and plated at 50 cells/l in the presence of EGF (20 ng/ml) (white bars) or FGF2 (10 ng/ml) with heparin (black bars). The 100% control represents the numbers of neurospheres generated from EGFR (ϩ/ϩ) embryos in either EGF or FGF2 and heparin. (C) Neurospheres generated (mean as a percentage control Ϯ SEM) from neural stem cells isolated from the E8.5 anterior neural plate of ROSA26-FGFR1(ϩ/Ϫ) tetraploid chimeric (controls; n ϭ 24) or ROSA26-FGFR1(Ϫ/Ϫ) tetraploid chimeric (n ϭ 25) embryos and plated at 10 cells/l in the presence of FGF2 (10 ng/ml) with heparin.
Growth Factor Concentration Has Little Effect on the Relative Fates of Neural Stem Cell Progeny
It has been shown previously that the levels of growth factor receptors and their ligands are dynamic throughout development. For example, levels of FGF2 increase during embryogenesis (Powell et al., 1991; Nurcombe et al., 1993; Weise et al., 1993) . The present findings that the numbers of neural stem cells isolated from the developing telencephalon increase during development and that growth factor concentration can modulate neural stem cell proliferation even at one stage of development, suggests that growth factor concentration may regulate neural stem cell proliferation in vivo. Having shown that neural stem cell proliferation is influenced by EGF and FGF2 concentration, we investigated whether growth factor concentration had any influence on the fates of the stem cell-derived progeny.
Previous work has revealed that FGF2 influences the types of progeny generated from E10 cortical precursor cells in a concentration-dependent manner (Qian et al., 1997) . When our neural stem cell-derived neurospheres are plated FIG. 5. Endogenous release of EGF or FGF2 does not influence neural stem cell proliferation. The number of neurospheres generated from neural stem cells isolated from the E14.5 GZ in the presence of the anti-FGF2 antibody (1.25 g/ml) is substantially reduced in the presence of FGF2 (10 ng/ml) with heparin compared to control (conAb and FGF2 ϩ heparin), but not in the presence of EGF (20 ng/ml) compared to control (conAb and EGF), at 50 cells/l (A) or 10 cells/l (C) plating densities. The number of neurospheres generated in the presence of the EGFR inhibitor (0.16 M PD) is also substantially decreased in the presence of EGF compared to control (DMSO ϩ EGF), but not in the presence of FGF2 and heparin compared to control (DMSO ϩ FGF2 ϩ heparin), at 50 cells/l (B) or 10 cells/l (D). n ϭ 6 embryos for each growth factor condition group at both high and low cell densities. on an adhesive substrate, then the cells will adhere and in the presence of fetal bovine serum will differentiate into neurons, astrocytes, and oligodendrocytes expressing phenotype-specific markers. Neurospheres that were generated from the E14.5 striatal GZ in the presence of optimal concentrations of either EGF (20 ng/ml) or FGF2 (10 ng/ml), or low concentrations of either growth factor (0.6 ng/ml) demonstrated multipotentiality when cultured in the presence of media containing fetal bovine serum (data not shown). In order to address the effect of EGF and FGF2 on the generation of neurons and glia independent of any unknown factors present in serum, we isolated EGF-and FGF-responsive neural stem cells (at low cell densities) in either high or low concentrations of growth factor and then allowed for differentiation in the same serum-free conditions. The data show that independent EGF-and FGFresponsive primary neural stem cells both demonstrate multilineage potential, regardless of growth factor concentration (Table 1) . These results are consistent with the results from the growth factor dose-dependent clonal analyses (see above). The proportion of neurons and oligodendrocytes decreased in the presence of lower concentrations of either EGF or FGF2, but the proportion of astrocytes (approximately 55%) remained constant. In low concentrations of FGF2 the percentage of O4 ϩ oligodendrocytes in the sampled cells was zero. However, since there is an obvious trend for a reduction in differentiated oligodendrocytes in low concentrations of both EGF and FGF2, we suggest that these conditions were likely not permissive for oligodendrocyte differentiation. Certainly, neurospheres generated in low concentrations of FGF2 and allowed to differentiate in the presence of low concentrations of FGF2 and 10% FBS also produce a very small percentage of O4 ϩ cells (data not shown). Neurospheres plated in FGF2 generate more neurons compared to neurospheres plated in EGF (Table 1) , which may suggest that FGF2-responsive stem cells are specified to produce more neurons than EGF-responsive stem cells. However, we cannot rule out the perhaps more likely possibility that the growth factors were influencing the progeny of the stem cells (rather than the stem cells themselves) in a selective manner. Thus, although neural stem cell proliferation is regulated by growth factor concentration, both EGF-and FGF-responsive neural stem cells maintain their multilineage potential in the presence of varying growth factor concentrations.
Neural Stem Cell Proliferation Is Additive with the Combination of EGF and FGF2 at Low Cell Density
Neural stem cells present in the E14.5 GZ have EGF and FGF2 receptor signaling capacity, and either factor alone is sufficient to activate neural stem cell proliferation in serum-free, defined media. To determine directly the sensitivity of neural stem cell proliferation to EGF or FGF2, we assayed the numbers of neurospheres generated in the presence of EGF, FGF2, and the combination of both mitogens at very low cell plating densities. The numbers of neurospheres generated in the presence of FGF2 was greater than the number of neurospheres generated in the presence of EGF from 1 cell/l to 10 cells/l (Fig. 6A) . This observation is consistent with the previous finding that at a lower cell density (10 cells/l) and optimal concentrations of EGF (20 ng/ml) and FGF2 (10 ng/ml) a greater number of neurospheres are generated in FGF2. Furthermore, from 1 cell/l to 10 cells/l the number of neurospheres generated in the combination of EGF and FGF2 was additive (Fig. 6A) . Conversely, the numbers of neurospheres generated in EGF or FGF2 at optimal concentrations and high cell plating density (50 cells/l) were equivalent (Fig. 3A) . We further examined the role of facilitative cell nonautonomous effects on neural stem cell proliferation over the lower range of cell densities (1 versus 10 cells/l) by plating the same small absolute number of cells (2000) in different volumes. Neural stem cell proliferation was increased more than 10-fold in EGF and in FGF2 at the higher density when the same absolute numbers of cells were plated in different volumes (Fig. 6B) . Therefore, all of these data suggest that neural stem cells may have a differential sensitivity to EGF and FGF2, which can be revealed over relatively low cell densities, but that is obscured at high cell densities due to additional cell nonautonomous effects produced by the release of unknown endogenous growth factors.
One possible interpretation for the enhanced proliferation of neural stem cells in the presence of combined EGF and FGF2 compared to either factor alone over all of the lower cell densities (Fig. 6A) is that EGF and FGF2 interact synergistically to elicit a stem cell to divide. To test this possibility, high and low growth factor concentrations were combined to determine if the number of E14.5 neural stem cell-derived neurospheres was greater than additive (i.e., substantially greater than the estimated number of neurospheres generated when adding the numbers of neurospheres seen when only a single high or low growth factor concentration was present). The combination of high and low concentrations of EGF and FGF2 did not appear to interact synergistically to promote neural stem cell proliferation (Fig. 6C) . These data argue that EGF and FGF2 can independently elicit the proliferation of EGF-and FGFresponsive stem cells.
One possible explanation for the additivity in the number of neurospheres generated at low cell densities in the presence of the combined growth factors (and lack of synergy) is that there are separate populations of neural stem cells that are responsive to either EGF or FGF2. To further test the putative heterogeneity in the neural stem cell population we estimated the minimal frequency of neural stem cells at limiting dilutions. The lack of specific morphological or biochemical criteria for identifying neural stem cells in vivo presents a major problem when attempting to determine the frequency of stem cells in the GZ. Currently, the best biochemical marker for neural precursor cells is the intermediate filament protein nestin (Lendahl et al., 1990) ; however, it is not specific to neural stem cells and is expressed in other cell types including developing cardiac cells (Zimmerman et al., 1994) and neural progenitors. We took advantage of the neurosphere assay, in which one neurosphere represents the proliferation of a single self-renewing, multipotential neural stem cell , and applied a limiting dilution analysis (Lefkovits and Waldmann, 1984; Sharrock et al., 1990; Bellows and Aubin, 1989) in order to determine the specific frequency of neural stem cells (among a population of VZ neural precursors) that proliferate in response to either EGF, FGF2, or the combination of EGF and FGF2. The linear relationship between the percentages of wells without neurospheres and the numbers of cells plated per well suggest that separate single neural stem cells are proliferating in EGF and FGF2 to give rise to neurospheres. When plating at limiting dilutions, the proportion of culture wells with no neurospheres (i.e., negative wells) is defined by the zero term of the Poisson distribution: F 0 ϭ e Ϫx . The number of cells required to allow for the isolation of one stem cell (x ϭ 1) can be calculated using F 0 ϭ e Ϫ1 ϭ 0.37 or 37%. Based on the Poisson distribution and the intersect at the 37% level, we estimated the minimal frequency of neural stem cells in the E14.5 VZ precursor population to be 0.6% in the presence of EGF, 1.3% in the presence of FGF2, and 2% (additive) in the presence of both EGF and FGF2 combined (Fig. 6D) . These data reveal that there are separate EGF- and   FIG. 6 . At low cell densities, the frequency of E14.5 neural stem cells varies in EGF and FGF2 alone and proliferation is additive in the presence of EGF plus FGF2. (A) When decreasing numbers of cells were plated in 200 l of media the number of neurospheres generated in the presence of both EGF (20 ng/ml) and FGF2 (10 ng/ml) with heparin was additive compared to the numbers generated in either growth factor alone at all cell densities tested (equal to and less than 10 cells/l). (B) When the same absolute number of cells (2000 cells) was plated in different volumes, a substantial facilitative community effect was observed, and at both densities the number of neurospheres generated in both EGF and FGF2 was additive compared to other growth factors alone. (C) When cells are plated (10 cells/l) in varying combined concentrations of growth factors, EGF and FGF2 do not interact synergistically to promote neural stem cell proliferation. (D) Cells plated at limiting dilution (in 200 l vol of media) revealed that the frequency in which at least one neural stem cell will proliferate to form a neurosphere (37% mark on the y axis) varied in the presence of either EGF (20 ng/ml), FGF2 (10 ng/ml) with heparin, or both EGF and FGF2. n ϭ 6 -7 embryos for each cell density and growth factor condition for all four experiments.
FGF-sensitive populations of embryonic telencephalic neural stem cells.
EGF-Responsive Neural Stem Cells Are Lineage Descendents of FGF2-Responsive Neural Stem Cells
The above experiments revealed that EGFR and FGFR1 signaling is critical for EGF-and FGF2-dependent neural stem cell proliferation, respectively, and that FGF-and EGF-responsive neural stem cells may represent two separate subpopulations within the E14.5 GZ. Because both FGFR1 (Ϫ/Ϫ) embryos and ROSA26-FGFR1 (Ϫ/Ϫ) tetraploid chimeras die by approximately E9.5, in order to determine if a lineage relationship exists between FGF-responsive neural stem cells and EGF-responsive neural stem cells (which normally do not begin to emerge until E11.5-E13.5 in the striatal GZ) we generated diploid chimeras in which wildtype cells (CD1) allowed the embryos with cells harboring an FGFR1
(Ϫ/Ϫ) mutation to survive until E14.5. We hypothesized that if the EGF-responsive neural stem cells arose independently of the FGF2-responsive neural stem cells during development, then an FGFR1 null mutation would not influence the numbers of EGF-responsive stem cells isolated, but would cause an attenuation of the FGF2-responsive stem cells (similar to what was observed from the E8.5 ROSA26-FGFR1 (Ϫ/Ϫ) tetraploid chimera results). The relative contribution (percentage chimerism) of cells from either the ROSA26-FGFR1 (Ϫ/Ϫ) lineage or the ROSA26-FGFR1 (ϩ/Ϫ) lineage in the diploid chimeras was estimated from histological sections on the basis of ␤-galactosidase (␤-gal) staining (Fig. 7A) . Single hemispheres obtained from E14.5 telencephalons from ROSA26-FGFR1 (ϩ/Ϫ) diploid chimeras (controls, n ϭ 8) demonstrated a mean percentage chimerism of 34.8% within the striatal GZ, while those obtained from ROSA26-FGFR1 (Ϫ/Ϫ) diploid chimeras (n ϭ 8) demonstrated a mean percentage chimerism of 12.4% within the striatal GZ. These estimates are consistent with previous chimerism data from diploid chimeric embryos analyzed between E9.5 and E10.5, showing that fewer mutant cells (compared to controls) contribute to anterior neural structures (Ciruna et al., 1997) . Cells isolated from the striatal GZs of the opposite hemispheres were cultured in serum-free conditions in the presence of optimal concentrations of either FGF2 (10 ng/ml) or EGF (20 ng/ml). The numbers of ␤-gal ϩ neurospheres (containing all blue cells derived from either the ROSA26-FGFR1 (Ϫ/Ϫ) stem cells or derived from the ROSA26-FGFR1 (ϩ/Ϫ) stem cells) and the numbers of ␤-gal Ϫ neurospheres (containing all white cells derived from wild-type CD1 stem cells) were quantified after 7 days in culture (Fig. 7B) . The results show that the proliferation of both FGF-and EGF-responsive neural stem cells is decreased by greater than 95% in E14.5 ROSA26-FGFR1 (Ϫ/Ϫ) diploid chimeras (n ϭ 8) compared to ROSA26-FGFR1 (ϩ/Ϫ) diploid chimeric controls (n ϭ 8) (Fig. 7C) . The number of neurospheres generated in both EGF and FGF2 is enhanced by ϳ50% and by over twofold, respectively, from wild-type CD1-derived neural stem cells (␤-gal Ϫ ) in the ROSA26-FGFR1 (Ϫ/Ϫ) diploid chimeras compared to the ROSA26-FGFR1 (ϩ/Ϫ) diploid chimeric controls (Fig. 7C ). This suggests that in these diploid chimeras, wild-type neural stem cells can partially compensate for the overall reduction in the numbers of neural stem cells in the GZ in vivo by increasing their symmetrical divisions prior to E14.5. However, since there is an overall 50% decrease in the total number of neurospheres generated from the ROSA26-FGFR1 (Ϫ/Ϫ) diploid chimeras (ROSA and CD1 combined) compared to the ROSA26-FGFR1 (ϩ/Ϫ) diploid chimeric controls (data not shown), this increase in the number of neurospheres in vitro may only represent a very minor compensatory effect. Thus, these results are consistent with the hypothesis that EGF-responsive neural stem cells are lineage descendents of the FGF-responsive neural stem cells during telencephalic development.
DISCUSSION
Simple neural lineage models depict a single selfrenewing, multipotential stem cell giving rise to progenitor cells that are more restricted in their potential to generate differentiated neurons, astrocytes, and oligodendrocytes, depending on factors that influence either their proliferation, differentiation, or survival (Gage et al., 1995; Temple and Qian, 1995; Johe et al., 1996; . The present data builds upon this fundamental notion to support an alternative model in which separate, lineage-related stem cells are also present in the E14.5 GZ (Fig. 8 ). This conclusion is based on the evidence that: (1) only FGFresponsive neural stem cells are present at early developmental stages, but these cells can generate EGF-responsive stem cells when passaged in vitro and EGF-responsive stem cells can be isolated at later developmental stages in vivo; (2) at low cell densities greater numbers of neural stem cells proliferate in response to FGF2 than to EGF; (3) neural stem cell proliferation is additive in the presence of both mitogens; (4) there is a differential frequency of EGF-and FGF-responsive stem cells at limiting dilutions, suggesting that these two stem cell populations are separate; and (5) a mutation in the FGFR1 gene which prevents the expansion of the FGF2-dependent neural stem cells during telencephalic development also prevents the emergence of the EGF-responsive neural stem cells. Unknown endogenous factors (other than EGF or FGF2) can facilitate the proliferation of FGF-and especially EGF-responsive subpopulations to form neurospheres, and at higher cell densities serve to obscure the differences between the EGF-and FGF-responsive stem cells. Despite the presence of separate EGF-and FGF-responsive stem cells, both types are selfrenewing and capable of generating neurons, astrocytes, and oligodendrocytes.
FIG. 7.
In ROSA26-FGFR1(Ϫ/Ϫ) diploid chimeras, both FGF2-and EGF-responsive neural stem cell proliferation is diminished from E14.5
A Neural Stem Cell That Proliferates in Response to FGF2 Emerges Earliest in Embryonic Telencephalic Development
The expression of FGFR1 within the E8.5 neural plate indicates that neuroepithelial cells at this early stage of development are competent to proliferate in response to FGF2, the primary ligand for this FGFR subtype (Ornitz and Leder, 1992; Johnson and Williams, 1993) . Using the in vitro clonal neurosphere assay for neural stem cells, we showed that only FGF-responsive neural stem cells are present as early as E8.5 within the anterior neural plate, near the onset of neural development in the postgastrulating mouse embryo. The substantial attenuation of E8.5 neural stem cell proliferation observed in mice lacking a functional FGFR1 (ROSA26-FGFR1 (Ϫ/Ϫ) tetraploid chimeras) suggests that the mitogenic signal provided by FGF2 is primarily mediated by FGFR1. However, FGF2 may also signal through other FGFR family members to cause a small percentage of the FGF2-dependent neural stem cells to proliferate at this early stage of neural development. For example, FGFR2 has been shown to be expressed in the early embryonic GZ (Orr-Urtreger et al., 1991) . The neurospheres generated in FGF2 can be subcloned in vitro in the presence of EGF or FGF2, suggesting that the FGFresponsive neural stem cells are the lineage precursors to the EGF-responsive neural stem cells. Our evidence from the ROSA26-FGFR1 (Ϫ/Ϫ) mouse diploid chimeric analyses demonstrates that this lineage relationship between FGFresponsive and EGF-responsive neural stem cells also exists in vivo. Since both EGF-and FGF-responsive neural stem cells that contained the FGFR1 (Ϫ/Ϫ) mutation were significantly diminished from the E14.5 striatal GZ, our data strongly suggest that the ontogeny of the EGF-responsive neural stem cell is not independent of the FGF2-responsive neural stem cell, but rather that the FGF2-responsive neural stem cell gives rise to the EGF-responsive neural stem cell during telencephalic development. It is possible that the FGF-responsive stem cell population secretes an unknown factor that is necessary to promote the development of an EGF-responsive stem cell population. However, this is unlikely since we would expect that in the diploid chimeric mice, the FGF-responsive stem cells with the wild-type CD1 background would be able to provide this unknown factor to allow the ROSA26-FGFR1 (Ϫ/Ϫ) (ϩ/Ϫ) control) cells to proliferate in response to EGF at E14.5. The neural stem cell-derived neurospheres in the present study also demonstrate multilineage potential (generating neurons, astrocytes, and oligodendrocytes), confirming their stem cell status. There is a ϳ7-fold increase in the number of neural stem cells (in similar cell density cultures) isolated between E8.5 (anterior neural plate) and E14.5 (striatal GZ) in the present study. The estimated frequency of neurosphere-forming stem cells as a percentage of the total viable GZ cells cultured in vitro increases from ϳ0.3% at E8.5 to at least 2% at E14.5. Since only the striatal GZ was used to determine stem cell frequency at E14.5 and not the cortical GZ (the other major derivative of the anterior neural plate), the magnitude of the increase in neural stem cell frequency may be underestimated. Nonetheless, these results reveal that the neural stem cell population substantially expands through symmetrical divisions within the GZ throughout the early stages of telencephalic development. These initial observations provide a basis for further examining when and to what extent symmetrical stem cell divisions occur during this time period.
Between E13.5 and E15.5 there is an increase in the EGF responsiveness of neural stem cells isolated from the cortical GZ and striatal GZ. An early FGF2 responsiveness of neural precursors has been observed in multipotential precursors from the E10 telencephalon (Kilpatrick and Bartlett, 1993) and neural stem cells from the E10 spinal cord (Kalyani et al., 1997) . Different regions of the developing telencephalon are known to have a differential pattern of maturation. There is evidence for caudorostral and ventrodorsal gradients of maturation in the forebrain, with the most rostral (olfactory bulbs) and most dorsal (cortex) regions developing last (Smart and Smart, 1982) . The absence of substantial EGF-responsiveness of neural stem cells may reflect the "immaturity" of this telencephalic region. The stronger expression of the EGFR in ventral forebrain regions at early stages is consistent with this possibility (Eagleson et al., 1996) . One possible mechanism for the increased responsiveness to EGF may involve the upregulation of EGFR expression. In accordance with this interpretation, Burrows et al. (1997) have shown that very few stem cells present in the E12-E15 rat cortical germinal zone normally proliferate in response to EGF, which is ontologically similar to the E10 -E13 mouse cortical germinal zone. However, when the number of EGFRs is increased in these cells using a retroviral construct then neural stem cell proliferation in response to EGF is enhanced at these early ages. This suggests that a critical ratio of ligand: receptor was necessary to elicit EGF-dependent proliferation of neural stem cells that were present, but relatively unresponsive (Burrows et al., 1997) . If only a single stem cell population exists, then an enhanced EGF response in the EGFR-transfected cells could be interpreted as the precocious response of a single stem cell to EGF. However, it is equally plausible that if separate EGF-and FGFresponsive stem cell populations were present in the GZ, both types of stem cells can be transfected with the EGFR construct, enhancing their responsiveness to EGF. Indeed, one novel prediction from the present results is that if both EGF-and FGF-responsive stem cells can be transfected with the EGFR construct, then the additive effects on neurosphere formation at cell low densities in the presence of EGF and FGF2 combined would disappear.
The FGFR1 (Ϫ/Ϫ) mutation is embryonic lethal (between E7.5 and E9.5) and mutant mice demonstrate severe axial patterning defects (Deng et al., 1994; Yamaguchi et al., 1994) . Embryos with a less severe phenotype at E8.5 displayed relatively small and disorganized neural folds (Yamaguchi et al., 1994) . This suggests that although cells of the dorsal midline ectoderm are specified to become neural, the FGFR1 (Ϫ/Ϫ) neural stem cells present at this early stage of development may be unable to proliferate in response to FGF2 to expand the population, which may be a necessary antecedent to neurogenesis. Our present results reveal that FGFR1 is critical not only for FGF2-dependent proliferation of neural stem cells at E8.5, but also for the expansion of this population throughout telencephalic development. The EGFR (Ϫ/Ϫ) lethal phenotype, on the other hand, was dependent on genetic background, with the age of death ranging from implantation to postnatal day 20 (Miettinen et al., 1995; Sibilia and Wagner, 1995; Threadgill et al., 1995) . Epithelial proliferation and differentiation were compromised in many tissues. Neural development in early stages of embryogenesis was relatively spared, but by E18 there appeared to be reduced cortical size in both the cerebrum and cerebellum, with a concomitant GZ expansion (Threadgill et al., 1995) . The EGFR (Ϫ/Ϫ) mutation appeared to affect multiple mechanisms (including cell survival, proliferation, differentiation, and migration) regulating neuronal and glial cell types (Sibilia et al., 1998) . The present results show that the EGF-induced proliferation of neural stem cells isolated from the EGFR (Ϫ/Ϫ) forebrain GZ is drastically reduced, but that FGFresponsiveness of neural stem cells in these mutant mice is not affected. Since early neural development is apparently normal in these mutants, these results indicate that EGFresponsiveness of neural stem cells is not necessary at early stages, but may subsequently be required for the production of progenitor cells at later stages of development (as judged by the late neural phenotype in the EGFR (Ϫ/Ϫ) mice). Furthermore, it will be important to determine if the progenitor cells produced by telencephalic stem cells are dependent upon EGF for the proper production of neurons and glia from older embryonic and early postnatal periods, when the EGF-dependent neurodegeneration is most prevalent (Sibilia et al., 1998) .
Separate EGF-and FGF-Responsive Neural Stem Cell Populations Coexist at Later Stages of Telencephalic Development
There are two possible mechanisms by which FGF2 and EGF can influence neural stem cell proliferation at different stages of development. The first is that the neural stem cell possesses only FGFR1 signaling at E8.5, but by E14.5-15.5 has developed both EGFR and FGFR1 signaling capacity, either of which alone may be sufficient to activate the neural stem cell. It is conceivable that the differences in EGF-and FGF2-dependent proliferation may actually reflect the ability of these mitogens to regulate later progenitor cell proliferation within a stem cell lineage (neuro-sphere), rather than differentially influencing two separate stem cell populations to divide. These differences, however, would still support the notion that neural stem cell lineages can be differentially regulated by EGF and FGF2. The second possibility is that the FGF-responsive neural stem cell at E8.5 is the precursor in a lineage to the EGFresponsive stem cell, but that both of the separate EGF-and FGF-responsive neural stem cells are present in the E14.5-15.5 GZ (Fig. 8) . Indeed, this hypothesis is strongly supported by our analysis of the ROSA26-FGFR1 (Ϫ/Ϫ) diploid chimeras. Although EGFR and FGFR expression appears to be ubiquitous among neural stem cells and their progeny in primary neurospheres, the variation in receptor expression within individual cells provides at least some initial correlative evidence to suggest that cells which express mostly EGFR or mostly FGFR are maintained as differentially responsive cells, and perhaps some of which may be stem cells with the capacity to self-renew. It is clear from the present results that neural stem cell proliferation in EGF or FGF2 is concentration-dependent, and others have shown that stem cell proliferation in the presence of EGF also depends on the levels of EGFR (Burrows et al., 1997) . The fact that high levels of EGFR are required for some neural stem cells to divide (Burrows et al., 1997) offers the possibility that cells expressing high levels of one receptor proliferate in the presence of ligand in a concentrationdependent manner, but that low levels of the other receptor render the cells unresponsive regardless of ligand concentration.
Previous reported estimates of the frequency of FGF2-responsive multipotential precursor cells in the embryonic forebrain ranged from approximately 4% (at E10) to 5% (at E17) (Kilpatrick and Bartlett, 1995) . On the other hand, the frequency of E12 and E14 cortical GZ cells isolated in conditioned media with the characteristics of stem cells was approximately 7% (Davis and Temple, 1994) . Limiting dilution analyses revealed that the minimal frequency of neural stem cells in the E14.5 GZ is 0.6% in the presence of EGF, 1.3% in the presence of FGF2, and 2% in the combination of EGF and FGF2, and indicates that stem cells are differentially recruited on the basis of what growth factor is present. The higher frequencies reported by others may have included progenitor cells as well as true stem cells. Alternatively, our estimated frequencies of stem cells using limiting dilution may be low because of the present finding that cell nonautonomous effects of cell density, that are not due to the endogenous release of EGF or FGF2, more than proportionally increase the number of stem cells. Thus, cell plating density is a critical variable when determining maximal stem cell frequency. Nonetheless, all of these estimates reveal that the stem cell pool makes up only a small percentage of the total GZ precursor population. The present data suggest a large increase in the absolute number of telencephalic stem cells between E8.5 and E14.5-15.5, but recent estimates of the numbers of stem cells in the adult forebrain subependyma (Morshead et al., 1998) suggest that the stem cell population may not substantially increase from later embryogenesis to adulthood.
Neural Stem Cell Proliferation Is Differentially Sensitive to EGF, FGF2, and Separate Cell Nonautonomous Effects
Neural stem cell proliferation also may be secondarily modulated via cell-cell communication in response to a primary mitogenic signal. The present results reveal that growth factor concentration regulates the proliferation of neural stem cells in a cell density-dependent manner. The secretion of diffusable factors by responsive cells may subserve such cell nonautonomous effects. Furthermore, the concentration of the factor(s) will be greater when many secreting cells are in close proximity than when only a few dispersed cells are present. Therefore, the density of cells plated in a volume of media is critical for enabling endogenous secreted factor(s) to influence neural stem cell proliferation in our serum-free conditions. Others (Hulspas et al., 1997) have demonstrated that the proliferation of neural stem cells is density-dependent even at cell densities ranging from 50 to 200 cells/l. Furthermore, Hulspas et al. (1997) showed that by mixing cells of a ROSA26 genetic background with cells of a Balb/c genetic background that virtually all of their stem cell colonies at such high cell densities were clonal (i.e., did not contain a mixture of cells with both genotypes). This was also true in our results with ROSA26-FGFR1 (Ϫ/Ϫ) and ROSA26-FGFR1 (ϩ/Ϫ) diploid chimeras. When striatal GZ tissue, containing a mixture of ROSA and CD1 cells, was dissociated and cultured at low cell density in vitro, the neurospheres that were generated were either composed of entirely ␤-gal ϩ (blue) cells or entirely CD1 (white) cells and no mixed clones were observed.
In the present study, we demonstrated that there is a facilitative effect of increased density on the proliferation of both FGF-and EGF-responsive neural stem cell subpopulations, but which may have a greater influence EGFresponsive stem cell proliferation. We have also shown that neural stem cell proliferation (at both high and low cell densities and in the presence of optimal concentrations of exogenous EGF or FGF2) is independent of the endogenous secretion of FGF2 or EGF by neural precursors in response to the primary exogenous mitogenic signal. Therefore, the nature of the observed cell nonautonomous effects remains to be determined. Proliferation of neuroepithelial cells has been shown to depend on the production of IGF-1, acting itself as a survival factor (Drago et al., 1991) . Cellular interactions mediated by secreted factors also may regulate receptor levels. For example, KGF (FGF7) is a potent inducer of TGF␣ in keratinocytes and causes activation and down modulation of the EGFR (Dlugosz et al., 1994) , influencing keratinocyte responsiveness indirectly by activating an EGFR-mediated signal for proliferation. Thus, mitogenic signals from other members of the FGF growth factor family or the upregulation of survival factors, such as IGF-1, may mediate the cell nonautonomous effects which potentiate the FGF-and EGF-responsive neural stem cell proliferation. The source of these factors also remains undetermined. Even at high cell densities, pure populations of oligodendrocyte precursors do not divide in the absence of exogenous growth factors, suggesting that mitogenic signals for these precursors originate from cell types other than the precursors themselves (Barres et al., 1992) . In the present in vitro assay, primary cultured neural stem cells are part of a heterogeneous population of GZ cells, including postmitotic progenitors. Therefore, it will be of interest to determine if the cell density-dependent proliferation is mediated by stem cell interactions exclusively, by progenitor/postmitotic cells, or by a mixture of all of these cell types.
The Different Neural Stem Cells Maintain Multipotentiality Irrespective of Growth Factor Conditions
The independent EGF-and FGF-responsive neural stem cells isolated here both demonstrate multilineage potential. Consistent with previous results on expanding E10 cortical precursors (Qian et al., 1997) , the proportion of O4 ϩ oligodendroglial progeny increases, with both increasing FGF2 and EGF concentrations in the present study. However, two of the present results are notably different from these previous findings. First, the proportion of GFAP ϩ astrocytes was similar in all growth factor conditions assayed (Table  1) . Qian et al. (1997) reported that the glial cells generated in cortical stem cell clones were predominantly of the oligodendrocyte lineage (98%), and that only in the presence of astrocyte-meningeal cell-conditioned media (plus FGF2) would the percentage of glial-containing clones that contain astrocytes increase substantially. The present results demonstrate that neural stem cells isolated from the striatal GZ generate all three major neural cell types. One possible explanation for these differences is that there are temporal (E10 vs E14.5) and spatial (cortical GZ vs striatal GZ) restrictions on the competence of stem cells to generate neurons and glia in response to growth factor concentration. Second, the proportion of MAP2 ϩ neurons decreased with decreasing concentration of both FGF2 and EGF (Table 1) . This result stands in contrast to the previous finding that the percentage of ␤-tubulin III ϩ neurons present in cortical stem cell clones increased to Ͼ90% in low concentrations of FGF2 (Qian et al., 1997) . Low FGF2 concentrations may delay neuronal differentiation of progenitors rather than act on the stem cells directly. Thus, the increase in ␤-tubulin III ϩ cells (Qian et al., 1997) may represent a selective increase in the proportion of immature neurons which then results in a corresponding decrease in the proportion of more differentiated (MAP2 ϩ ) neurons (Table 1) . It is possible that the instructive capacity of EGF and FGF2 may only be revealed when a very small number of cells (i.e., small number of cells/clone) are present in a well, as was the case in the study reported by Qian et al. (1997) . Perhaps the same cell nonautonomous effects that facilitate neural stem cell proliferation from a primary culture are also present within neurospheres (i.e., a relatively greater number of cells/clone) to ensure the multipotentiality of the stem cell by maintaining relatively similar proportions of various differentiated progeny, even under various growth factor conditions. The presence of EGFR and FGFR1 on all neural stem cell-derived cells within a neurosphere indicates that the degree to which neuronal and glial fate may be altered also depends on the ability of EGF or FGF2 to act in a inductive manner on the progeny of neural stem cells (rather than on the stem cells themselves) to promote progenitor cell survival, differentiation, or proliferation. Although it remains formally possible that EGF and FGF2 can differentially instruct stem cells to generate neurons and glia (Johe et al., 1996) , the cells isolated by Qian et al. (1997) may be a later precursor in the stem cell lineage, that may or may not be multipotential, compared to the stem cell isolated in the neurosphere assay which is multipotential and self-renewing. Indeed, we would suggest that the true neural stem cells (EGF-or FGF-responsive) always retain their undifferentiated multipotential state throughout life and that inductive environmental signals influence the differentiation of the progeny of the stem cells (although not the stem cells themselves). For example, BDNF (Ahmed et al., 1995) and IGF-1 (Arsenijevic and Weiss, 1998) have been shown to enhance the differentiation of neurons from EGF-derived neurospheres, while bone morphogenetic proteins (BMPs) (Gross et al., 1996) promote astrocyte differentiation from EGF-derived neurospheres.
The presence of different classes of stem cells during development raises the possibility that the early specification of telencephalic compartments may be partly due to the establishment of different stem cell populations. Although in the present study both EGF-and FGF-responsive stem cells retain their multilineage potential in defined serum-free conditions, it is possible that there are unique intrinsic components in each of the separate stem cell lineages. The interaction between such distinct intracellular components and selective exogenous factors (e.g., BDNF, IGF-1, BMPs) may act to regulate the production of specific types or numbers of neuronal and glial progeny in a temporally and spatially dependent manner.
